Prevention of anatomic defects in congenital adrenal hyperplasia produced by estradiol-17-beta in rats.
D000311:Adrenal Glands / Q000187:drug effects; D000312:Adrenal Hyperplasia, Congenital / Q000139:chemically induced* / Q000517:prevention & control*; D000818:Animals; D002987:Clitoris / Q000002:abnormalities; D003345:Corticosterone / Q000494:pharmacology*; D004965:Estrogen Antagonists; D005260:Female; D005333:Fetus / Q000187:drug effects; D006913:Hydroxysteroid Dehydrogenases; D006984:Hypertrophy; D007021:Hypospadias / Q000139:chemically induced* / Q000517:prevention & control; D008297:Male; D008431:Maternal-Fetal Exchange; D010502:Perineum; D011247:Pregnancy; D011270:Pregnancy, Animal; D051381:Rats; D013737:Testis / Q000378:metabolism; D013739:Testosterone / Q000096:biosynthesis / Q000494:pharmacology*
D004965:Estrogen Antagonists; D013739:Testosterone; D006913:Hydroxysteroid Dehydrogenases; D003345:Corticosterone